Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
RHO1:FRA
Roche CAD Hedged CDR
7,30 €
-0,68%
(-0,050) 1D
30-апр., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for RHO1...
Open
7,30 €
High
7,30 €
Low
7,30 €
Mkt. cap
330,83 млд
Avg. vol.
10,00
Volume
0,00
52-wk high
8,55 €
52-wk low
5,30 €
No. of employees
113 миң
News stories
From sources across the web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche CAD Hedged CDR
CEOThomas Schinecker
Employees113 миң
Founded1896-ж., 1-окт.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
15,92 млд
15,92 млд
15,75 млд
15,75 млд
Cost of goods sold
3,87 млд
3,87 млд
4,21 млд
4,21 млд
Cost of revenue
3,87 млд
3,87 млд
4,21 млд
4,21 млд
Research and development expenses
3,11 млд
3,11 млд
3,15 млд
3,15 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,29 млд
3,29 млд
3,59 млд
3,59 млд
Operating expense
6,30 млд
6,30 млд
6,82 млд
6,82 млд
Total operating expenses
10,17 млд
10,17 млд
11,03 млд
11,03 млд
Operating income
5,75 млд
5,75 млд
4,72 млд
4,72 млд
Other non operating income
4,00 млн
4,00 млн
-1,50 млн
-1,50 млн
EBT including unusual items
4,79 млд
4,79 млд
3,69 млд
3,69 млд
EBT excluding unusual items
5,46 млд
5,46 млд
4,37 млд
4,37 млд
Income tax expense
878,00 млн
878,00 млн
709,00 млн
709,00 млн
Effective tax rate
18,31%
18,31%
19,20%
19,20%
Other operating expenses
-110,50 млн
-110,50 млн
77,50 млн
77,50 млн
Net income
3,70 млд
3,70 млд
2,74 млд
2,74 млд
Net profit margin
23,27%
23,27%
17,36%
17,36%
Earnings per share
-
-
-
-
Interest and investment income
56,50 млн
56,50 млн
45,00 млн
45,00 млн
Interest expense
-304,00 млн
-304,00 млн
-289,50 млн
-289,50 млн
Net interest expenses
-247,50 млн
-247,50 млн
-244,50 млн
-244,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
6,53 млд
6,53 млд
5,50 млд
5,50 млд
Gain or loss from assets sale
-
-
-21,50 млн
-21,50 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer